Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 10.6B | 14.8B | 14.5B | 12.1B |
Cost of revenue | 6.7B | 9.8B | 9.4B | 7.4B |
Gross profit | 4.0B | 5.0B | 5.1B | 4.7B |
Operating expense | ||||
Research & development | 590M | 667M | 602M | 531M |
Selling general and admin | 3.0B | 3.9B | 3.9B | 2.8B |
Other operating expenses | -12M | — | — | — |
Operating income | 439M | 370M | 605M | 1.3B |
Non operating interest income | ||||
Income | 67M | 70M | 20M | 14M |
Expense | 408M | 512M | 415M | 207M |
Other income expense | -387M | -32M | -2.9B | -35M |
Pretax income | -289M | -103M | -2.7B | 1.1B |
Tax provision | 37M | -34M | 4M | 83M |
Net income | -638M | 2.7B | -2.4B | 1.3B |
Basic EPS | -1.3 | 5.3 | -4.8 | 2.6 |
Diluted EPS | -1.3 | 5.3 | -4.8 | 2.5 |
Basic average shares | 510M | 506M | 504M | 502M |
Diluted average shares | 510M | 506M | 504M | 502M |
EBITDA | 1.6B | 1.8B | 2.0B | 2.2B |
Net income from continuing op. | -326M | -69M | -2.7B | 1.0B |
Minority interests | -11M | -7M | -12M | -11M |
Preferred stock dividends | — | — | — | — |